Research Dedicated to 20-year Multiple Meningioma Survivor

Meningioma Mommas is continuing its longtime collaboration with Harvard researcher, Dr. Hiro Wakimoto by awarding him a $7,500 grant for the next phase of his Photo-Dynamic Oncolytic Virus Therapy research, which has revealed promising results in the treatment of meningioma brain tumors. “This work showed for the first time that our genetically engineered virus therapy…

Details

Promising Photodynamic Therapy Update

Meningioma Mommas has awarded Harvard researcher, Dr. Hiro Wakimoto a $5,000 grant to advance his team’s photodynamic therapy research. Dr. Wakimoto shares the following encouraging updates: “We have been particularly interested in the potential power of an engineered virus–to be specific, genetically engineered herpes simplex virus–to act as an agent able to kill cancer cells…

Details

NYU Neurosurgeon and Researcher Dedicates Grant to Meningioma Mommas Longtime Member

New York University neurosurgeon and researcher, Dr. Nader Delavari, is dedicating his research project, “Enzymatic Modification of the Consistency of Firm Tumors may Facilitate their Safe Resection” to Meningioma Mommas member, Debbie Arnold Burnett, who lost her 21-year-meningioma battle on June 22, 2020. Debbie joined Meningioma Mommas in 2003 and freely shared her battle to treat…

Details

Dynamic Duo: Dr. Hiroaki Wakimoto and Dr. Robert Martuza Awarded $10,000 Grant Honoring National Brain Tumor Awareness Month

Meningioma Mommas has awarded a second grant for $10,000 to Harvard researchers, Dr. Hiroaki Wakimoto and Dr. Robert Martuza for their project, “How to Best Activate Anti-tumor Immune Cells Triggered by Oncolytic Herpes Simplex Viruses (oHSVs) to Attack and Destroy High Grade Meningiomas”.  This is phase one of their project and Meningioma Mommas is diligently…

Details

Meningioma Mommas Awards Second Grant to “Team Colorado” University of Colorado Researchers

Meningioma Mommas has awarded a $29,042 grant to University of Colorado researchers,  Dr. Kevin Lillehei, Dr. Michael Graner, Dr. Philip Tatman and their support team (Team Colorado!) to continue their focus on, “Pre-clinical trial evaluation of HDAC inhibitors for the treatment of meningiomas.” Project Summary: Meningiomas are a common primary brain tumor, accounting for 36% of…

Details

Meningioma Mommas–Funding new research for better treatment of meningioma brain tumors!

Meningioma Mommas is asking for help to fund an exciting new project by the team of University of Colorado researchers we have previously funded.  Please help us help the researchers find better treatment options for meningioma patients by donating via our own Donate page. From the researchers: PROJECT SUMMARY “Meningiomas are a common brain tumor, considered…

Details

Stanford Study Seeks Safer Scans

Meningioma Mommas has chosen Stanford University as its latest grant recipient. Meningioma Mommas awarded a $10,000 award to neurosurgeon and researcher, Dr. Melanie Hayden Gephart for her project, Gadolinium-based Contrast and Meningioma Monitoring. Gadolinium-based contrast agents (GBCA) are a class of intravenous drugs commonly used to enhance magnetic resonance imaging (MRI) studies. GBCA aid in the…

Details